Magee-Womens Hospital of UPMC and CMU Develop App for High-Risk Pregnant Women | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Magee-Womens Hospital of UPMC and CMU Develop App for High-Risk Pregnant Women

May 1, 2017
by Heather Landi
| Reprints

Maternal-fetal medicine specialists at Magee-Womens Hospital of UPMC collaborated with decision scientists at Carnegie Mellon University (CMU), also based in Pittsburgh, to develop and test a personalized smartphone application designed to combat preterm birth by engaging a typically hard-to-reach population of pregnant women.

The findings of a pilot study, reported in the Journal of Medical Internet Research mHealth and uHealth, indicate that the app was successful in providing accessible and personalized obstetrical care, designed specifically to target preterm birth risk by focusing on high-risk pregnant women.

Preterm birth, the leading cause of neonatal death or long-term disability, is on the rise in the United States with approximately one of every 10 births occurring prior to 37 weeks of gestation, according to the researchers, and these rates are disproportionately high among some socioeconomic groups, including African Americans and families living in poverty. These patient groups often are the hardest to reach due to limited access to and attendance at routine prenatal care, the researchers contend.

“Mobile phone apps are a great way to engage a vulnerable population in their health care because approximately 86 percent of American adults own a mobile phone, regardless of racial and ethnic groups,” Tamar Krishnamurti, Ph.D., lead author and assistant research professor of engineering and public policy at CMU, said in a statement. “Moreover, 20 percent of all smartphone owners downloaded a pregnancy app in 2015. Although hundreds of pregnancy-related apps exist, few have been developed through a scientific process that is patient-centered and grounded in behavioral decision research.”

To develop the app, CMU decision scientists and Magee maternal-fetal medicine specialists conducted interviews and user testing with medical experts and women recruited from high-risk groups. Sixteen study participants from Magee’s outpatient clinic, which specializes in high-risk pregnancies, were then provided a smartphone with the preloaded app and a digital weight scale. Through the app, participants were queried daily over three months to assess such risk factors as rate of weight gain, smoking, alcohol consumption, depression and intimate partner violence. Because transportation to appointments is often a barrier to prenatal care, free transportation using Uber was incorporated into the app’s functionality.

The researchers found that use of the app was higher among participants at higher risk, as reflected in such factors as poorer daily moods or being earlier in their pregnancies. Participants had an attendance rate of 84 percent at prenatal appointments compared with the clinic norm of 50 percent. The researchers also conservatively estimated cost savings of $450 per patient over three months.

Participants voluntarily logged into the app to complete daily risk assessments, and computer algorithms delivered patient-specific risk feedback and recommendations tailored to individual users. When the app detected high-risk events such as intimate partner violence or thoughts of suicide, it sent real-time alerts to medical staff. Women were then contacted directly and linked to appropriate medical and social service resources.

“While we do not understand why certain socioeconomic groups are at a higher-risk for preterm birth, we do know that prenatal care that starts early in pregnancy is critical for a healthy baby and mother,” Hyagriv Simhan, M.D., professor, obstetrics, gynecology, and reproductive sciences, University of Pittsburgh School of Medicine, and chief, division of maternal-fetal medicine at Magee, said in a statement. “This pilot shows that smartphone apps are a promising and potentially cost-saving way to provide personalized care for the highest-risk patients.”

The researchers’ next steps include conducting a randomized controlled trial over the entire pregnancy of participants and evaluating the effects of the app on behavioral and clinical outcomes, including adverse birth outcomes.


Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More



Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.